Evidence map›Paper›PMID 39685597›Full record

ArticleJournal of clinical medicine2024

Optical Attenuation Coefficient-Based En Face Optical Coherence Tomography Imaging for the Reliable Assessment of the Ellipsoid Zone.

Hiroaki Sakai, Riku Kuji, Yoshikiyo Moriguchi, Shoko Yamashita, Ayako Takamori, Masato Tamura, Toshihiro Mino, Masahiro Akiba, Hiroshi Enaida

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Hiroaki SakaiDepartment of Ophthalmology, Faculty of Medicine, Saga University, 5-1-1 Nabeshima, Saga 849-8501, Japan.
Riku KujiResearch & Development Division, Topcon Corporation, 75-1 Hasunuma-cho, Itabashi-ku, Tokyo 174-8580, Japan.
Yoshikiyo MoriguchiResearch & Development Division, Topcon Corporation, 75-1 Hasunuma-cho, Itabashi-ku, Tokyo 174-8580, Japan.ORCID 0000-0003-4734-6861
Shoko YamashitaDepartment of Ophthalmology, Faculty of Medicine, Saga University, 5-1-1 Nabeshima, Saga 849-8501, Japan.
Ayako TakamoriClinical Research Center, Saga University Hospital, 5-1-1 Nabeshima, Saga 849-8501, Japan.
Masato TamuraResearch & Development Division, Topcon Corporation, 75-1 Hasunuma-cho, Itabashi-ku, Tokyo 174-8580, Japan.
Toshihiro MinoResearch & Development Division, Topcon Corporation, 75-1 Hasunuma-cho, Itabashi-ku, Tokyo 174-8580, Japan.ORCID 0000-0001-9913-3265
Masahiro AkibaResearch & Development Division, Topcon Corporation, 75-1 Hasunuma-cho, Itabashi-ku, Tokyo 174-8580, Japan.
Hiroshi EnaidaDepartment of Ophthalmology, Faculty of Medicine, Saga University, 5-1-1 Nabeshima, Saga 849-8501, Japan.ORCID 0000-0001-7808-3182

Funding

JSPS KAKENHI 22K09792Topcon Topcon Research Grants
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ellipsoid zoneen faceoptical attenuation coefficientSS-OCTstructural integrity

Identifiers

PMID39685597
PMCPMC11642224

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.